Related references
Note: Only part of the references are listed.Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm
Arinao Ndadza et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Sandra Lopez-Leon et al.
SCIENTIFIC REPORTS (2021)
COVID-19 Pandemic and Africa: From the Situation in Zimbabwe to a Case for Precision Herbal Medicine
Collet Dandara et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2021)
Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis
Innocent G. Asiimwe et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication
Diana M. Rydberg et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Pharmacogenomics of COVID-19 therapies
Takuto Takahashi et al.
NPJ GENOMIC MEDICINE (2020)
Identification of environmental and genetic factors that influence warfarin time in therapeutic range
Mariana R. Botton et al.
GENETICS AND MOLECULAR BIOLOGY (2020)
Herbal Remedies: Throwing Off Phenotype Prediction-A Culprit for Pharmacogenomic-Guided Drug Therapy and Drug Safety
Collet Dandara et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia
Lei Zhang et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Warfarin Dose and CYP2C Gene Cluster: An African Ancestral-Specific Variant Is a Strong Predictor of Dose in Black South African Patients
Arinao Ndadza et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2019)
The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future
Arinao Ndadza et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2019)
Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings
Zipporah Kamuren et al.
BMC HEALTH SERVICES RESEARCH (2018)
Clinical pharmacogenomics of carvedilol: the stereo-selective metabolism angle
Barbara M. Parker et al.
PHARMACOGENOMICS (2018)
Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis
Jean Jacques Noubiap et al.
LANCET GLOBAL HEALTH (2018)
Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations
Nicholas Ekow Thomford et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2018)
Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens
Jamison Norwood et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Epidemiology of venous thromboembolism in Africa: a systematic review
C. Danwang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
High plasma concentrations of dolutegravir in patients with ABCG2 genetic variants
Kiyoto Tsuchiya et al.
PHARMACOGENETICS AND GENOMICS (2017)
Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation
Liuh Ling Goh et al.
PLOS ONE (2017)
Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1
Hiroki Yagura et al.
BMC INFECTIOUS DISEASES (2017)
Venous Thromboembolism Requiring Extended Anticoagulation Among HIV-Infected Patients in a Rural, Resource-Constrained Setting in Western Kenya
John Kanyi et al.
ANNALS OF PHARMACOTHERAPY (2017)
Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation
Francoise Pinillos et al.
BMC INFECTIOUS DISEASES (2016)
Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol
Anastasios Lymperopoulos et al.
CURRENT DRUG METABOLISM (2016)
In Vitro Reversible and Time-Dependent CYP450 Inhibition Profiles of Medicinal Herbal Plant Extracts Newbouldia laevis and Cassia abbreviata: Implications for Herb-Drug Interactions
Nicholas Ekow Thomford et al.
MOLECULES (2016)
Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa
Babatunde O. Sonuga et al.
AFRICAN JOURNAL OF PRIMARY HEALTH CARE & FAMILY MEDICINE (2016)
Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options
Bruce Sheldon Stambler et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2015)
Hypertension in Zimbabwe: A meta-analysis to quantify its burden and policy implications
Mutsa Pamela Mutowo et al.
WORLD JOURNAL OF META-ANALYSIS (2015)
Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition
Nicholas E. Thomford et al.
PHARMACEUTICALS (2015)
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
L. B. Ramsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Updates on the Clinical Evidenced Herb-Warfarin Interactions
Beikang Ge et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Cytochrome P450 pharmacogenetics in African populations: implications for public health
Collet Dandara et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa
Ripudaman K. Bains et al.
BMC GENETICS (2013)
Review of epidemiology and management of atrial fibrillation in developing countries
Tu N. Nguyen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
ABCB1 Variation and Treatment Response in AIDS Patients: Initial Results of the Henan Cohort
Peng Zhu et al.
PLOS ONE (2013)
High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients
Marelize Swart et al.
PHARMACOGENETICS AND GENOMICS (2013)
PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients
Marelize Swart et al.
BMC MEDICAL GENETICS (2012)
Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo
Cong Xu et al.
DRUG METABOLISM AND DISPOSITION (2012)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
S. A. Scott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users
Anu M. Neuvonen et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2011)
Performance outcomes of a pharmacist-managed anticoagulation clinic in the rural, resource-constrained setting of Eldoret, Kenya
I. Manji et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
D. Wang et al.
PHARMACOGENOMICS JOURNAL (2011)
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
Dirk Sibbing et al.
CIRCULATION (2010)
Genome-wide analysis of the structure of the South African Coloured Population in the Western Cape
Erika de Wit et al.
HUMAN GENETICS (2010)
Presence of the CYP2B6 516G > T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients
Verena Gounden et al.
AIDS RESEARCH AND THERAPY (2010)
Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies
Elizabeth B. Daily et al.
PHARMACOGENOMICS (2009)
The Genetic Structure and History of Africans and African Americans
Sarah A. Tishkoff et al.
SCIENCE (2009)
The pharmacokinetics and interactions of ivermectin in humans - A mini-review
Aranzazu Gonzalez Canga et al.
AAPS JOURNAL (2008)
African Genetic Diversity: Implications for Human Demographic History, Modern Human Origins, and Complex Disease Mapping
Michael C. Campbell et al.
Annual Review of Genomics and Human Genetics (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe
Christopher Nyakutira et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells
Y Kameyama et al.
PHARMACOGENETICS AND GENOMICS (2005)
Cytochrome P4502C8: Substrates, inhibitors, pharmacogenetics, and clinical relevance
RA Totah et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
YY Shi et al.
CELL RESEARCH (2005)
Frequency of concurrent use of warfarin with potentially interacting drugs
AK Wittkowsky et al.
PHARMACOTHERAPY (2004)
CYP2C9 genetic variants and losartan oxidation in a Turkish population
MO Babaoglu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Genetic polymorphism of CYP1A2 in ethiopians affecting induction and expression: Characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1
E Aklillu et al.
MOLECULAR PHARMACOLOGY (2003)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
Share Paper
